RxDoctor Payments Data

Jamie Oubre, NP

Family · Lagrange, GANPI 1144859224

Payments from drug & device makers

$500in general payments, 2019–2025

Across 28 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$174
  • Novo Nordisk$72
  • Bayer$43
  • Lilly USA, LLC$40
  • Sanofi-aventis U.S. LLC$34
  • Astellas Pharma US Inc$29
  • plus $109 from 6 others

What the payments were for

  • Food & beverage$500100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$500 in reported general payments places this provider in the 55th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$30,235
Medicare patients
186
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate32$37,853
OzempicSemaglutide28$31,881
TrulicityDulaglutide17$29,378
EliquisApixaban21$27,632
Tresiba Flextouch U-100Insulin Degludec13$9,010
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,851
XareltoRivaroxaban13$8,335
Janumet XrSitagliptin Phos/Metformin Hcl11$6,816
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,701
Albuterol Sulfate HfaAlbuterol Sulfate51$1,640
Atorvastatin Calcium173$1,276
Nano 2nd Gen Pen NeedlePen Needle, Diabetic18$1,168
Amlodipine Besylate195$880
Fluticasone Propionate70$806
Levothyroxine Sodium76$703

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet Xr$16$44,66943 claims
Novo NordiskOzempic$72$31,88128 claims
Lilly USA, LLCTrulicity$40$29,37817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,258 family providers in Georgia.

Other family in Lagrange

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →